Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of Health Canada Patents covering NCGC00024452-03.

Client Email

Product

NCGC00024452-03
HEALTH CANADA PATENTS

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

NCGC00024452-03

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

11 API Suppliers, 3 USDMF, 1 JDMF, 2 EU WC, 5 NDC API, 6 Listed Suppliers, $ API Reference Price

11 API Suppliers
3 USDMF
1 JDMF
2 EU WC
5 NDC API
6 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

19 Drugs in Development

19 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports

API Reference Price
API Exports
API Imports

INTERMEDIATES

1 API Suppliers

1 API Suppliers

FINISHED DOSAGE FORMULATIONS

23 FDF Dossiers, 5 FDA Orange Book, 13 Europe, 2 Canada, 1 South Africa, 2 Listed Dossiers

23 FDF Dossiers
5 FDA Orange Book
13 Europe
2 Canada
1 South Africa
2 Listed Dossiers

RELATED EXCIPIENT COMPANIES

7 DKSH, 3 Boai NKY Pharmaceuticals Ltd, 3 Gangwal Healthcare, 4 ACG Worldwide, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 DFE Pharma, 1 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 3 Lonza Capsugel, 5 Microlex e.U, 1 Pharmatrans-Sanaq, 1 Pluviaendo, 2 Prachin Chemical, 1 Qualicaps, 4 Roquette, 1 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Sigachi Industries, 1 Ulanqab Kema New Material, 2 Vasa Pharmachem

7 DKSH
3 Boai NKY Pharmaceuticals Ltd
3 Gangwal Healthcare
4 ACG Worldwide
2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
1 DFE Pharma
1 Gangwal Chemicals
1 Ingredion Pharma Solutions
3 Lonza Capsugel
5 Microlex e.U
1 Pharmatrans-Sanaq
1 Pluviaendo
2 Prachin Chemical
1 Qualicaps
4 Roquette
1 Seppic
2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shanghai Welltone Material Technology Co., Ltd
1 Sigachi Industries
1 Ulanqab Kema New Material
2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

13 Fillers, Diluents & Binders, 10 Lubricants & Glidants, 9 Disintegrants & Superdisintegrants, 8 Empty Capsules, 7 Thickeners and Stabilizers, 6 Coating Systems & Additives, 4 Co-Processed Excipients, 3 Direct Compression, 3 Coloring Agents, 2 Film Formers & Plasticizers, 1 API Stability Enhancers, 1 Solubilizers, 1 Controlled & Modified Release, 1 Granulation, 1 Emulsifying Agents, 1 Taste Masking

13 Fillers, Diluents & Binders
10 Lubricants & Glidants
9 Disintegrants & Superdisintegrants
8 Empty Capsules
7 Thickeners and Stabilizers
6 Coating Systems & Additives
4 Co-Processed Excipients
3 Direct Compression
3 Coloring Agents
2 Film Formers & Plasticizers
1 API Stability Enhancers
1 Solubilizers
1 Controlled & Modified Release
1 Granulation
1 Emulsifying Agents
1 Taste Masking

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 22 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
22 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 10 Finished Drug Prices, 1 Annual Reports

2 US Medicaid Prescriptions
10 Finished Drug Prices
1 Annual Reports

MARKET PLACE

7 APIs, 4 FDF Dossiers

7 APIs
4 FDF Dossiers

PATENTS & EXCLUSIVITIES

7 US Patents, 1 US Exclusivities, 1 Health Canada Patents

7 US Patents
1 US Exclusivities
1 Health Canada Patents

$ API Ref.Price (USD/KG) : 26,958 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

1 All

01 1Janssen Inc.

filter Patent Reset all filters

1 All

01 12368814

filter Product Reset all filters

1 All

01 1Miglustat

filter Dosage Reset all filters

1 All

01 1Capsules

filter Exp Date Reset all filters

1 All

01 12020-04-20

US Patents
US Exclusivities
Health Canada Patents

Product Main Page

01

Janssen Inc.

Miglustat

Formnext Forum

Not Confirmed

Janssen Inc.

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2020-04-20

Date Granted : 2010-09-07

Brand Name : ZAVESCA

Patent Number : 2368814

Filing Date : 2000-04-20

Strength per Unit : 100 mg

Dosage Form : Capsules

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2020-04-20

Date Granted : 2010-09-07

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?